chr2-207767199-C-T
Variant summary
Our verdict is Likely pathogenic. The variant received 6 ACMG points: 6P and 0B. PM2PP3_Strong
The NM_003468.4(FZD5):c.1541G>A(p.Gly514Asp) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 13/22 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_003468.4 missense
Scores
Clinical Significance
Conservation
Publications
- microphthalmia/coloboma 11Inheritance: AD Classification: STRONG Submitted by: G2P
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 6 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_003468.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| FZD5 | NM_003468.4 | MANE Select | c.1541G>A | p.Gly514Asp | missense | Exon 2 of 2 | NP_003459.2 |
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| FZD5 | ENST00000295417.4 | TSL:1 MANE Select | c.1541G>A | p.Gly514Asp | missense | Exon 2 of 2 | ENSP00000354607.3 | Q13467 | |
| FZD5 | ENST00000908573.1 | c.1541G>A | p.Gly514Asp | missense | Exon 2 of 2 | ENSP00000578632.1 | |||
| FZD5 | ENST00000937374.1 | c.1541G>A | p.Gly514Asp | missense | Exon 2 of 2 | ENSP00000607433.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 1453210Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 722306
GnomAD4 genome Cov.: 33
ClinVar
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at